The ICON Study: Outcomes After FMT for Patients With IBD and CDI

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

April 7, 2020

Study Completion Date

December 31, 2020

Conditions
Inflammatory Bowel DiseasesClostridium Difficile Infection
Interventions
DRUG

Fecal Microbiota Transplantation

Patients with at least 2 episodes of CDI and IBD will undergo a single FMT

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Indiana University

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

The Miriam Hospital

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT03106844 - The ICON Study: Outcomes After FMT for Patients With IBD and CDI | Biotech Hunter | Biotech Hunter